electroCore, Inc.
ECOR4.970USD
-0.025-0.50%
종가 09/19, 16:00（ET）시세는 15분 지연됩니다
37.11M시가총액
손실P/E TTM
자세한 내용은 electroCore, Inc. 회사
electroCore, Inc. is a commercial stage bioelectronic medicine and wellness company. It provides non-invasive vagus nerve stimulation (nVNS) technology platform. The Company’s product categories include Handheld, personal use medical devices for the management and treatment of certain medical conditions such as primary headache, and Handheld, personal use consumer products utilizing nVNS technology to promote general wellness and human performance. Its products include gammaCore, Truvaga and TAC-STIM. Its gammaCore Sapphire, is a prescription medical device that is used for a variety of primary headache conditions. Its Truvaga is a personal use consumer electronics general wellness product that does not require a prescription and is available direct-to-consumer from electroCore at www.truvaga.com. The Company’s TAC-STIM product is not a medical device and is not intended to diagnose, cure, mitigate, prevent, or treat a disease or condition.
회사 정보
종목 코드 ECOR
회사 이름electroCore, Inc.
상장일Jun 22, 2018
CEOMr. Daniel S. Goldberger
직원 수73
유형Ordinary Share
회계 연도 종료Jun 22
주소200 Forge Way
도시ROCKAWAY
증권 거래소NASDAQ Capital Market Consolidated
국가United States of America
우편 번호07866
전화19732900097
웹사이트https://www.electrocore.com/
종목 코드 ECOR
상장일Jun 22, 2018
CEOMr. Daniel S. Goldberger
회사 임원
이름
이름/직위
직위
주식 보유
변동
Mr. Daniel S. (Dan) Goldberger
Mr. Daniel S. (Dan) Goldberger
Chief Executive Officer, Director
Chief Executive Officer, Director
184.90K
+0.54%
Mr. Thomas M. (Tom) Patton, J.D.
Mr. Thomas M. (Tom) Patton, J.D.
Independent Director
Independent Director
102.78K
+22.69%
Mr. John P. Gandolfo
Mr. John P. Gandolfo
Independent Director
Independent Director
88.10K
+27.52%
Ms. Patricia Wilber
Ms. Patricia Wilber
Independent Director
Independent Director
72.33K
+35.66%
Ms. Elena Bonfiglioli
Ms. Elena Bonfiglioli
Director
Director
30.55K
--
Dr. Thomas J. Errico, M.D.
Dr. Thomas J. Errico, M.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Joshua S. Lev
Mr. Joshua S. Lev
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Julie A. Goldstein
Ms. Julie A. Goldstein
Independent Director
Independent Director
--
--
Mr. James C. Theofilos
Mr. James C. Theofilos
Director
Director
--
--
이름
이름/직위
직위
주식 보유
변동
Mr. Daniel S. (Dan) Goldberger
Mr. Daniel S. (Dan) Goldberger
Chief Executive Officer, Director
Chief Executive Officer, Director
184.90K
+0.54%
Mr. Thomas M. (Tom) Patton, J.D.
Mr. Thomas M. (Tom) Patton, J.D.
Independent Director
Independent Director
102.78K
+22.69%
Mr. John P. Gandolfo
Mr. John P. Gandolfo
Independent Director
Independent Director
88.10K
+27.52%
Ms. Patricia Wilber
Ms. Patricia Wilber
Independent Director
Independent Director
72.33K
+35.66%
Ms. Elena Bonfiglioli
Ms. Elena Bonfiglioli
Director
Director
30.55K
--
Dr. Thomas J. Errico, M.D.
Dr. Thomas J. Errico, M.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
수익 분석
통화: USD마지막 업데이트: Sun, Jul 6
통화: USD마지막 업데이트: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
사업별USD
이름
수익
비율
Rx gammaCore - Department of Veteran Affairs and Department of Defense
4.72M
70.26%
Truvaga
1.11M
16.46%
Outside the United States
513.00K
7.64%
Rx gammaCore - U.S. Commercial
289.00K
4.30%
TAC-STIM
90.00K
1.34%
지역별USD
이름
수익
비율
United States
6.21M
92.36%
United Kingdom
451.00K
6.71%
Other
47.00K
0.70%
Japan
15.00K
0.22%
사업별
지역별
사업별USD
이름
수익
비율
Rx gammaCore - Department of Veteran Affairs and Department of Defense
4.72M
70.26%
Truvaga
1.11M
16.46%
Outside the United States
513.00K
7.64%
Rx gammaCore - U.S. Commercial
289.00K
4.30%
TAC-STIM
90.00K
1.34%
주식 보유 통계
마지막 업데이트: Sun, Sep 14
마지막 업데이트: Sun, Sep 14
주주
주주 유형
주주
주주
비율
Zhang (Tianyi)
9.69%
Theofilos (Charles Steve)
5.86%
Hilve Holdings Ltd
5.70%
Errico (Thomas J.)
4.04%
AWM Investment Company, Inc.
3.56%
기타
71.15%
주주
주주
비율
Zhang (Tianyi)
9.69%
Theofilos (Charles Steve)
5.86%
Hilve Holdings Ltd
5.70%
Errico (Thomas J.)
4.04%
AWM Investment Company, Inc.
3.56%
기타
71.15%
주주 유형
주주
비율
Individual Investor
28.45%
Corporation
9.24%
Investment Advisor
7.58%
Investment Advisor/Hedge Fund
4.99%
Hedge Fund
2.65%
Research Firm
0.25%
Pension Fund
0.04%
기타
46.81%
기관 주식 보유
마지막 업데이트: Tue, Jul 1
마지막 업데이트: Tue, Jul 1
보고 기간
기관 수
보유 주식
비율
변동
2025Q2
83
3.54M
47.26%
+919.62K
2025Q1
79
2.97M
41.24%
+583.46K
2024Q4
81
2.54M
38.89%
+127.67K
2024Q3
72
2.68M
41.45%
+353.98K
2024Q2
75
2.58M
42.20%
+349.71K
2024Q1
80
2.10M
35.02%
-224.03K
2023Q4
78
2.23M
37.11%
+633.96K
2023Q3
84
2.11M
37.42%
+276.86K
2023Q2
89
1.49M
31.36%
-816.60K
2023Q1
91
1.66M
35.08%
-464.62K
더 보기
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
Zhang (Tianyi)
734.64K
9.9%
+734.64K
--
May 15, 2025
Theofilos (Charles Steve)
444.53K
5.99%
--
--
May 12, 2025
Errico (Thomas J.)
246.25K
3.32%
+10.00K
+4.23%
May 12, 2025
AWM Investment Company, Inc.
318.11K
4.29%
+154.97K
+95.00%
Mar 31, 2025
The Vanguard Group, Inc.
232.33K
3.13%
+63.41K
+37.54%
Mar 31, 2025
Goldberger (Daniel S)
142.23K
1.92%
-39.27K
-21.64%
Mar 17, 2025
Renaissance Technologies LLC
178.43K
2.4%
+46.64K
+35.39%
Mar 31, 2025
Happy Holstein Management, LLC
153.17K
2.06%
--
--
May 12, 2025
MAZ Partners, L.P.
115.52K
1.56%
-156.44K
-57.52%
May 13, 2025
더 보기
관련 ETF
이름
비율
데이터 없음
주식 배당금
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음
주식 분할
날짜
유형
비율
Feb 14, 2023
Merger
15→1
Feb 14, 2023
Merger
15→1
Feb 14, 2023
Merger
15→1
Feb 14, 2023
Merger
15→1
날짜
유형
비율
Feb 14, 2023
Merger
15→1
Feb 14, 2023
Merger
15→1
Feb 14, 2023
Merger
15→1
Feb 14, 2023
Merger
15→1
